MDCX · Medicus Pharma Ltd. · Debt
$2.56
+0.11 (+4.65%)
At close · Oct 28
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“This uncertainty, along with the Company's history of losses, indicates that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$3.10M
Shares
1.26M
Volume · Oct 28
4040
Avg daily vol (12 sessions)
77.08K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of secured debt | 2026-06-30 | USD 3,500,000 | 10-Q filed 2026-08-12 |
| Noncurrent loans payable | 2026-06-30 | USD 17,114 | 10-Q filed 2026-08-12 |
| Noncurrent secured debt | 2026-06-30 | USD 17,982,542 | 10-Q filed 2026-08-12 |
| Operating lease liabilities | 2026-06-30 | USD 137,330 | 10-Q filed 2026-08-12 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.